Using stem and progenitor cells to recapitulate kidney development and restore renal function

Current Opinion in Organ Transplantation

Volumn 19, Issue 2, 2014, Pages 140-144

  Murray, Patricia A ^a   Woolf, Adrian S ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

embryonic stem cells; induced pluripotent stem cells and kidney derived stem cells; mesenchymal stem cells

Indexed keywords

CELL SUBPOPULATION; CHRONIC KIDNEY DISEASE; CLINICAL EFFECTIVENESS; EMBRYONIC STEM CELL; GENE EXPRESSION; HUMAN; IMMUNOMODULATION; KIDNEY DEVELOPMENT; KIDNEY DISEASE; KIDNEY EPITHELIUM; KIDNEY FUNCTION; MESENCHYMAL STEM CELL; PARACRINE SIGNALING; PLURIPOTENT STEM CELL; REVIEW; STEM CELL;

ANIMALS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; KIDNEY; KIDNEY DISEASES; MESENCHYMAL STROMAL CELLS; STEM CELL TRANSPLANTATION;

EID: 84897110792     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0000000000000052     Document Type: Review

References (54)

1. Hammerman MR. Classic and current opinion in embryonic organ transplantation. Curr Opin Organ Transplant 2014; 19.
2. Wang Y, He J, Pei X, Zhao W. Systematic review and meta-analysis of mesenchymal stem/stromal cells therapy for impaired renal function in small animal models. Nephrology (Carlton) 2013; 18: 201-208.
3. Bentzon JF, Stenderup K, Hansen FD, et al. Tissue distribution and engraftment of human mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene. Biochem Biophys Res Commun 2005; 330: 633-640.
4. Zhuo W, Liao L, Fu Y, et al. Efficiency of endovenous versus arterial administration of mesenchymal stem cells for ischemia-reperfusion-induced renal dysfunction in rats. Transplant Proc 2013; 45:503-510.
5. Yu X, Lu C, Liu H, et al. Hypoxic preconditioning with cobalt of bone marrow mesenchymal stem cells improves cell migration and enhances therapy for treatment of ischemic acute kidney injury. PLoS One 2013; 8:e62703.
6. Teo GS, Ankrum JA, Martinelli R, et al. Mesenchymal stem cells transmigrate between and directly through tumor necrosis factor-a-activated endothelial cells via both leukocyte-like and novel mechanisms. Stem Cells 2012; 30:2472-2486.
7. Kuzma-Kuzniarska M, Rak-Raszewska A, Kenny S, et al. Integration potential of mouse and human bone marrow-derived mesenchymal stem cells. Differentiation 2012; 83:128-137.
8. Donizetti-Oliveira C, Semedo P, Burgos-Silva M, et al. Adipose tissue-derived stem cell treatment prevents renal disease progression. Cell Transplant 2012; 21:1727-1741.
9. Milwid JM, Ichimura T, Li M, et al. Secreted factors from bone marrow stromal cells upregulate IL-10 and reverse acute kidney injury. Stem Cells Int 2012; 2012:392050.
10. van Koppen A, Joles JA, van Balkom BW, et al. Human embryonic mesenchymal stem cell-derived conditioned medium rescues kidney function in rats with established chronic kidney disease. PLoS One 2012; 7:e38746.
11. Iglesias DM, El-Kares R, Taranta A, et al. Stem cell microvesicles transfer cystinosin to human cystinotic cells and reduce cystine accumulation in vitro. PLoS One 2012; 7:e42840.
12. Zhou Y, Xu H, Xu W, et al. Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro. Stem Cell Res Ther 2013; 4:34.
13. Harrison F, Yeagy BA, Rocca CJ, et al. Hematopoietic stem cell gene therapy for the multisystemic lysosomal storage disorder cystinosis. Mol Ther 2013; 21:433-444.
14. Cantaluppi V, Gatti S, Medica D, et al. Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by micro- RNA-dependent reprogramming of resident renal cells. Kidney Int 2012; 82:412-427.
15. Franquesa M, Herrero E, Torras J, et al. Mesenchymal stem cell therapy prevents interstitial fibrosis and tubular atrophy in a rat kidney allograft model. Stem Cells Dev 2012; 21:3125-3135.
16. Hu J, Zhang L, Wang N, et al. Mesenchymal stem cells attenuate ischemic acute kidney injury by inducing regulatory T cells through splenocyte interactions. Kidney Int 2013; 84:521-531.
17. Tan J, Wu W, Xu X, et al. Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial. JAMA 2012; 307:1169-1177.
18. Peng Y, Ke M, Xu L, et al. Donor-derived mesenchymal stem cells combined with low-dose tacrolimus prevent acute rejection after renal transplantation: a clinical pilot study. Transplantation 2013; 95:161-168.
19. Dave SD, Vanikar A, Trivedi HL, et al. Stem cells versus donor specific transfusions for tolerance induction in living donor renal transplantation: a single-center experience. Transplantation 2013; 95:155-160.
20. Lee H, Park JB, Lee S, et al. Intra-osseous injection of donor mesenchymal stem cell (MSC) into the bone marrow in living donor kidney transplantation; a pilot study. J Transl Med 2013; 11:96.
21. Reinders ME, de Fijter JW, Roelofs H, et al. Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study. Stem CellsTransl Med 2013; 2:107-111.
22. Montserrat N, Ramírez-Bajo MJ, Xia Y, et al. Generation of induced pluripotent stem cells from human renal proximal tubular cells with only two transcription factors, OCT4 and SOX2. J Biol Chem 2012; 287:24131-24138.
23. Wang WW, Wang W, Jiang Y, et al. Reprogramming of mouse renal tubular epithelial cells to induced pluripotent stem cells. Cytotherapy 2013; 15:578-585.
24. Freedman BS, Lam AQ, Sundsbak JL, et al. Reduced ciliary polycystin-2 in induced pluripotent stem cells from polycystic kidney disease patients with PKD1 mutations. J Am Soc Nephrol 2013; 24:1571-1586.
25. Cheng LT, Nagata S, Hirano K, et al. Cure of ADPKD by selection for spontaneous genetic repair events in Pkd1-mutated iPS cells. PLoS One 2012; 7:e32018.
26. Rak-Raszewska A, Wilm B, Edgar D, et al. Development of embryonic stem cells in recombinant kidneys. Organogenesis 2012; 8:125-136.
27. Nakayama KH, Lee CC, Batchelder CA, Tarantal AF. Tissue specificity of decellularized rhesus monkey kidney and lung scaffolds. PLoS One 2013; 8:e64134.
28. Narayanan K, Schumacher KM, Tasnim F, et al. Human embryonic stem cells differentiate into functional renal proximal tubular-like cells. Kidney Int 2013; 83:593-603.
29. Morizane R, Monkawa T, Fujii S, et al. Kidney specific protein-positive cells derived from embryonic stem cells reproduce tubular structures in vitro and differentiate into renal tubular cells. PLoS One 2013; 8:e64843.
30. Mae S, Shono A, Shiota F, et al. Monitoring and robust induction of nephrogenic intermediate mesoderm from human pluripotent stem cells. Nat Commun 2013; 4:1367.
31. Song B, Smink AM, Jones CV, et al. The directed differentiation of human iPS cells into kidney podocytes. PLoS One 2012; 7:e46453.
32. Hendry CE, Vanslambrouck JM, Ineson J, et al. Direct transcriptional reprogramming of adult cells to embryonic nephron progenitors. J Am Soc Nephrol 2013; 24:1424-1434.
33. Luo J, Zhao X, Tan Z, et al. Mesenchymal-like progenitors derived from human embryonic stem cells promote recovery from acute kidney injury via paracrine actions. Cytotherapy 2013; 15:649-662.
34. Smeets B, Boor P, Dijkman H, et al. Proximal tubular cells contain a phenotypically distinct, scattered cell population involved in tubular regeneration. J Pathol 2013; 229:645-659.
35. Bombelli S, Zipeto MA, Torsello B, et al. PKHhigh cells within clonal human nephrospheres provide a purified adult renal stem cell population. Stem Cell Res 2013; 11:1163-1177.
36. Fuente Mora C, Ranghini E, Bruno S, et al. Differentiation of podocyte and proximal tubule-like cells from a mouse kidney-derived stem cell line. Stem Cells Dev 2012; 21:296-307.
37. Ranghini E, Mora CF, Edgar D, et al. Stem cells derived from neonatal mouse kidney generate functional proximal tubule-like cells and integrate into developing nephrons in vitro. PLoS One 2013; 8:e62953.
38. Angelotti ML, Ronconi E, Ballerini L, et al. Characterization of renal progenitors committed toward tubular lineage and their regenerative potential in renal tubular injury. Stem Cells 2012; 30:1714-1725.
39. Rangel EB, Gomes SA, Dulce RA, et al. C-kit(+) cells isolated from developing kidneys are a novel population of stem cells with regenerative potential. Stem Cells 2013; 31:1644-1656.
40. Sallustio F, Costantino V, Cox SN, et al. Human renal stem/progenitor cells repair tubular epithelial cell injury through TLR2-driven inhibin-A and microvesicle- shuttled decorin. Kidney Int 2013; 83:392-403.
41. Harari-Steinberg O, Metsuyanim S, Omer D, et al. Identification of human nephron progenitors capable of generation of kidney structures and functional repair of chronic renal disease. EMBO Mol Med 2013; 5:1556-1568.
42. O'Neill JD, Freytes DO, Anandappa AJ, et al. The regulation of growth and metabolism of kidney stem cells with regional specificity using extracellular matrix derived from kidney. Biomaterials 2013; 34:9830-9841.
43. Simone S, Cosola C, Loverre A, et al. BMP-2 induces a profibrotic phenotype in adult renal progenitor cells through Nox4 activation. Am J Physiol Renal Physiol 2012; 303:F23-34.
44. Lee LM, Leung CY, Tang WW, et al. A paradoxical teratogenic mechanism for retinoic acid. Proc Natl Acad Sci U S A 2012; 109:13668-13673.
45. Peired A, Angelotti ML, Ronconi E, et al. Proteinuria impairs podocyte regeneration by sequestering retinoic acid. J Am Soc Nephrol 2013; 24:1756-1768.
46. Omer D, Harari-Steinberg O, Buzhor E, et al. Chromatin-modifying agents reactivate embryonic renal stem/progenitor genes in human adult kidney epithelial cells but abrogate dedifferentiation and stemness. Cell Reprogram 2013; 15:281-292.
47. Han SM, Lee HW, Bhang DH, et al. Canine mesenchymal stem cells are effectively labeled with silica nanoparticles and unambiguously visualized in highly autofluorescent tissues. BMC Vet Res 2012; 8:145.
48. Bai ZM, Deng XD, Li JD, et al. Arterially transplanted mesenchymal stem cells in a mouse reversible unilateral ureteral obstruction model: in vivo bioluminescence imaging and effects on renal fibrosis. Chin Med J (Engl) 2013; 126:1890-1894.
49. Qin J, Li K, Peng C, et al. MRI of iron oxide nanoparticle-labeled ADSCs in a model of hindlimb ischemia. Biomaterials 2013; 34:4914-4925.
50. UK Regenerative Medicine Safety Hub research programme. http://www. ukrmp.org.uk/hubs/safety-and-efficacy-focussing-on-imaging-technologies/. [Accessed 1 November 2013]
51. Tokar EJ, Person RJ, Sun Y, et al. Chronic exposure of renal stem cells to inorganic arsenic induces a cancer phenotype. Chem Res Toxicol 2012. [Epub ahead of print]
52. Thirabanjasak D, Tantiwongse K, Thorner PS. Angiomyeloproliferative lesions following autologous stem cell therapy. J Am Soc Nephrol 2010; 21: 1218-1222.
53. Vanikar AV, Trivedi HL, Shah PR, et al. Single-center experience on renal transplantation in primary focal and segmental glomerulosclerosis using hematopoietic stem cell transplantation in thymus, bone marrow, portal and peripheral circulation. Saudi J Kidney Dis Transpl 2013; 24:15-21.
54. Burger D, Gutsol A, Carter A, et al. Human cord blood CD133+ cells exacerbate ischemic acute kidney injury in mice. Nephrol Dial Transplant 2012; 27:3781-3789.